Long-term use of renin-angiotensin-system inhibitors after acute myocardial infarction is not associated with survival benefits: Analysis of data from the Korean acute myocardial infarction registry-national institutes of health registry

Long-term use of renin-angiotensin-system inhibitors after acute myocardial infarction is not associated with survival benefits: Analysis of data from the Korean acute myocardial infarction registry-national institutes of health registry

IntroductionRenin-angiotensin-system inhibitors (RASi) have shown survival benefits after acute myocardial infarction (MI), but the role of routine long-term use of RASi remains unclear. Thereby, we explored the therapeutic effects of RASi medication at 1-year follow-up from acute MI.MethodsUsing th...

Full description

Bibliographic Details
Main Authors: Chan Soon Park, Han-Mo Yang, Jeehoon Kang, Jung-Kyu Han, Kyung Woo Park, Hyun-Jae Kang, Bon-Kwon Koo, Ki-Bae Seung, Kwang Soo Cha, In-Whan Seong, Seung-Woon Rha, Myung Ho Jeong, Hyo-Soo Kim
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
acute myocardial infarction
renin-angiotensin-system inhibitor
angiotensin converting enzyme inhibitor
angiotensin II receptor blocker
mortality
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.994419/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.994419/full

Similar Items